Reveal Biosciences, Inc., a San Diego, CA-based leader in pathology AI, closed a Series A financing round of undisclosed amount.
The round was led by Intel Capital with participation from the GNI Group and PP Capital. In conjunction with the funding, Intel Capital Senior Director Ranjeet Alexis will join Reveal’s board.
The company intends to use the funds to expand its ImageDx™ online software platform with a pipeline of AI-based decision support tools.
Led by Claire Weston, PhD, Founder & CEO, Reveal is focused on improving global healthcare by creating a new generation of objective, data-powered pathology to characterize and detect disease. Its proprietary deep-learning platform, ImageDx™, delivers pathologists and scientists a novel class of actionable, quantitative data to advance research and enhance patient care. The company’s integrated data powered lab services have accelerated research for over 300 leading biopharma and academic institutions to date.